Article(id=1329529109954277563, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329529021181833654, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.07.015, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1702828800000, receivedDateStr=2023-12-18, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794914041269, onlineDateStr=2026-11-17, pubDate=1720540800000, pubDateStr=2024-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794914041269, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794914041269, creator=13701087609, updateTime=1794914041269, updator=13701087609, issue=Issue{id=1329529021181833654, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='7', pageStart='697', pageEnd='798', issueExtLink='null', onlineDate='null', pubDate='1720540800000', pubDateStr='2024-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794914020104, creator='13701087609', updateTime=1794988140586, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329839905410233043, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329529021181833654, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329839905410233044, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329529021181833654, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=786, endPage=793, ext={EN=ArticleExt(id=1329529110323376316, articleId=1329529109954277563, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress of small interfering RNA delivery system and chemical modification, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=
In 2018, the U.S. FDA approved the first small interfering RNA (siRNA) drug Patisiran, marking a brand-new era for RNA interference therapy. siRNA has developed rapidly in recent years due to its unique drug-forming advantages. Five siRNA drugs have been approved for marketing by the FDA. However, there are still many problems in targeting and efficacy in therapeutic applications. In order to develop new products with more potential value, it is necessary to deeply explore the current status of siRNA drug discovery and development. This article reviewed the advantages and hindrances of siRNA in drug discovery, focused on the research progress of chemical modification strategies and delivery systems of siRNA drugs, in order to provide a reference for the subsequent research.
, authors=Xiaodong ZHAO
1, 2, Huaying CHEN
2, Tao CHEN
1, 2, Yanmei ZHANG
1, 3, Hua LI
2, *, authorsList=Xiaodong ZHAO, Huaying CHEN, Tao CHEN, Yanmei ZHANG, Hua LI, authorCompany=null, correspAuthors=Hua LI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329529111023825085, articleId=1329529109954277563, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=小干扰RNA递送系统和化学修饰的研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=
2018年美国FDA批准首个小干扰RNA(small interfering RNA,siRNA)药物patisiran,标志着RNA干扰疗法进入一个新时代。siRNA凭借独特的成药优势,近些年发展迅速。目前已有5款siRNA药物获FDA批准上市。然而,其在治疗应用中的靶向性和疗效方面仍存诸多问题。为开发出具有更多潜在价值的新产品,有必要深入探讨siRNA药物研发现状。该文综述siRNA在成药方面的优势与阻碍,重点讨论siRNA药物的化学修饰策略和递送系统的研究进展。以期为后续研究提供参考。
, authors=赵晓东
1, 2, 陈华英
2, 陈涛
1, 2, 张燕媚
1, 3, 李华
2, *, authorsList=赵晓东, 陈华英, 陈涛, 张燕媚, 李华, authorCompany=null, correspAuthors=李华, authorNote=
, correspAuthorsNote=
李华,博士,研究员,研究方向:药物毒理。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=yL4dUSorHspXvxBz7aGN6Q==, magXml=JzB69CDSM9MrONFxk9QDdw==, pdfUrl=null, pdf=NUeUYNvTp0KXJ6XbK5dL3Q==, pdfFileSize=1588660, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=UrbaeOqWSwCTlAm41gjdQA==, mapNumber=null, fund=null)}, authors=[Author(id=1329529113095811272, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529113238417611, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, authorId=1329529113095811272, language=EN, stringName=Xiaodong ZHAO, firstName=Xiaodong, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, address=
1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
2.Shanghai Innostar Biotech CO., Ltd., Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529113305526476, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, authorId=1329529113095811272, language=CN, stringName=赵晓东, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, address=
1.中国医药工业研究总院,上海 201203
2.上海益诺思生物技术股份有限公司,上海 201203, bio={"content":"
赵晓东,硕士研究生,研究方向:药物毒理。
"}, bioImg=null, bioContent=
赵晓东,硕士研究生,研究方向:药物毒理。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529111778799806, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, xref=1., ext=[AuthorCompanyExt(id=1329529111841714367, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529111778799806, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1329529111854297280, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529111778799806, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1329529112806404289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, xref=2., ext=[AuthorCompanyExt(id=1329529112848347330, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112806404289, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Shanghai Innostar Biotech CO., Ltd., Shanghai 201203, China), AuthorCompanyExt(id=1329529112860930243, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112806404289, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海益诺思生物技术股份有限公司,上海 201203)])]), Author(id=1329529113410384078, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529113624293584, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, authorId=1329529113410384078, language=EN, stringName=Huaying CHEN, firstName=Huaying, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.Shanghai Innostar Biotech CO., Ltd., Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529113741734097, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, authorId=1329529113410384078, language=CN, stringName=陈华英, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.上海益诺思生物技术股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529112806404289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, xref=2., ext=[AuthorCompanyExt(id=1329529112848347330, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112806404289, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Shanghai Innostar Biotech CO., Ltd., Shanghai 201203, China), AuthorCompanyExt(id=1329529112860930243, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112806404289, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海益诺思生物技术股份有限公司,上海 201203)])]), Author(id=1329529113859174611, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529114115027158, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, authorId=1329529113859174611, language=EN, stringName=Tao CHEN, firstName=Tao, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, address=
1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
2.Shanghai Innostar Biotech CO., Ltd., Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529114240856279, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, authorId=1329529113859174611, language=CN, stringName=陈涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, address=
1.中国医药工业研究总院,上海 201203
2.上海益诺思生物技术股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529111778799806, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, xref=1., ext=[AuthorCompanyExt(id=1329529111841714367, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529111778799806, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1329529111854297280, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529111778799806, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1329529112806404289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, xref=2., ext=[AuthorCompanyExt(id=1329529112848347330, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112806404289, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Shanghai Innostar Biotech CO., Ltd., Shanghai 201203, China), AuthorCompanyExt(id=1329529112860930243, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112806404289, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海益诺思生物技术股份有限公司,上海 201203)])]), Author(id=1329529114324742361, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529114517680348, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, authorId=1329529114324742361, language=EN, stringName=Yanmei ZHANG, firstName=Yanmei, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 3, address=
1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
3.Shenzhen Innostar Institute of Biomedical Safety Evaluation and Research Co., Ltd., Shenzhen 518000, Guangdong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529114689646813, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, authorId=1329529114324742361, language=CN, stringName=张燕媚, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 3, address=
1.中国医药工业研究总院,上海 201203
3.深圳市益诺思生物医药安全评价研究院有限公司,广东 深圳 518000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529111778799806, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, xref=1., ext=[AuthorCompanyExt(id=1329529111841714367, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529111778799806, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1329529111854297280, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529111778799806, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1329529112965787844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, xref=3., ext=[AuthorCompanyExt(id=1329529112990953669, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112965787844, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
3.Shenzhen Innostar Institute of Biomedical Safety Evaluation and Research Co., Ltd., Shenzhen 518000, Guangdong Province, China), AuthorCompanyExt(id=1329529113003536582, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112965787844, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
3.深圳市益诺思生物医药安全评价研究院有限公司,广东 深圳 518000)])]), Author(id=1329529114828058847, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329529115050356961, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, authorId=1329529114828058847, language=EN, stringName=Hua LI, firstName=Hua, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, *, address=
2.Shanghai Innostar Biotech CO., Ltd., Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529115159408866, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, authorId=1329529114828058847, language=CN, stringName=李华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, *, address=
2.上海益诺思生物技术股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529112806404289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, xref=2., ext=[AuthorCompanyExt(id=1329529112848347330, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112806404289, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Shanghai Innostar Biotech CO., Ltd., Shanghai 201203, China), AuthorCompanyExt(id=1329529112860930243, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112806404289, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海益诺思生物技术股份有限公司,上海 201203)])])], keywords=[Keyword(id=1329529115385901283, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, language=EN, orderNo=1, keyword=small interfering RNA), Keyword(id=1329529115461398756, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, language=EN, orderNo=2, keyword=RNA interference), Keyword(id=1329529115570450662, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, language=EN, orderNo=3, keyword=delivery system), Keyword(id=1329529117374001382, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, language=EN, orderNo=4, keyword=chemical modification), Keyword(id=1329529117642436839, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, language=CN, orderNo=1, keyword=小干扰RNA), Keyword(id=1329529117785043176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, language=CN, orderNo=2, keyword=RNA干扰), Keyword(id=1329529117957009641, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, language=CN, orderNo=3, keyword=递送系统), Keyword(id=1329529118108004586, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, language=CN, orderNo=4, keyword=化学修饰)], refs=[Reference(id=1329529118292553963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Fire A, Xu S, Montgomery MK,
et al. Potent and specific genetic interference by double-stranded RNA in
Caenorhabditis elegans[J]. Nature, 1998, 391(6669): 806-811., articleTitle=null, refAbstract=null), Reference(id=1329529118422577388, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Raja MAG, Katas H, Amjad MW. Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA[J]. Asian J Pharm Sci, 2019, 14(5): 497-510., articleTitle=null, refAbstract=null), Reference(id=1329529118590349549, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Iwakawa HO, Tomari Y. Life of RISC: formation, action, and degradation of RNA-induced silencing complex[J]. Mol Cell, 2022, 82(1): 30-43., articleTitle=null, refAbstract=null), Reference(id=1329529118682624238, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Sheu-Gruttadauria J, Macrae IJ. Structural foundations of RNA silencing by Argonaute[J]. J Mol Biol, 2017, 429(17): 2619-2639., articleTitle=null, refAbstract=null), Reference(id=1329529118762316015, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Ryther RCC, Flynt AS, Phillips JA,
et al. SiRNA therapeutics: big potential from small RNAs[J]. Gene Ther, 2005, 12(1): 5-11., articleTitle=null, refAbstract=null), Reference(id=1329529118825230576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Shegokar R, Shaal LA, Mishra PR. SiRNA delivery: challenges and role of carrier systems[J]. Pharmazie, 2011, 66(5): 313-318., articleTitle=null, refAbstract=null), Reference(id=1329529118942671089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Judge AD, Sood V, Shaw JR,
et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA[J]. Nat Biotechnol, 2005, 23(4): 457-462., articleTitle=null, refAbstract=null), Reference(id=1329529119039140082, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Hu B, Zhong LP, Weng YH,
et al. Therapeutic siRNA: state of the art[J]. Signal Transduct Target Ther, 2020, 5(1): 101., articleTitle=null, refAbstract=null), Reference(id=1329529119102054643, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang MM, Bahal R, Rasmussen TP,
et al. The growth of siRNA-based therapeutics: updated clinical studies[J]. Biochem Pharmacol, 2021, 189: 114432., articleTitle=null, refAbstract=null), Reference(id=1329529119173357812, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Biscans A, Caiazzi J, Davis S,
et al. The chemical structure and phosphorothioate content of hydrophobically modified siRNAs impact extrahepatic distribution and efficacy[J]. Nucleic Acids Res, 2020, 48(14): 7665-7680., articleTitle=null, refAbstract=null), Reference(id=1329529119278215413, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Berk C, Civenni G, Wang YL,
et al. Pharmacodynamic and pharmacokinetic properties of full phosphorothioate small interfering RNAs for gene silencing
in vivo[J]. Nucleic Acid Ther, 2021, 31(3): 237-244., articleTitle=null, refAbstract=null), Reference(id=1329529119387267318, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=李倩, 陈锐, 胡蓓. 小干扰RNA(siRNA)药物药代动力学特征及生理药代动力学建模现状[J]. 药学学报, 2022, 57(10): 3146-3156., articleTitle=null, refAbstract=null), Reference(id=1329529119466959095, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Gangopadhyay S, Gore KR. Advances in siRNA therapeutics and synergistic effect on siRNA activity using emerging dual ribose modifications[J]. RNA Biol, 2022, 19(1): 452-467., articleTitle=null, refAbstract=null), Reference(id=1329529119596982520, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhou C, Chattopadhyaya J. Challenges in the chemistry of small interfering RNA as potential therapeutics to inhibit cellular mRNA expression[J]. Reference Module Chem Mol Sci Chem Eng, 2013, doi: 10.1016/B978-0-12-409547-2.05337-3., articleTitle=null, refAbstract=null), Reference(id=1329529119752171769, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Chernikov IV, Vlassov VV, Chernolovskaya EL. Current development of siRNA bioconjugates: from research to the clinic[J]. Front Pharmacol, 2019, 10: 444., articleTitle=null, refAbstract=null), Reference(id=1329529119865417978, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Imaeda A, Tomoike F, Hayakawa M,
et al.
N6-methyl adenosine in siRNA evades immune response without reducing RNAi activity[J]. Nucleosides Nucleotides Nucleic Acids, 2019, 38(12): 972-979., articleTitle=null, refAbstract=null), Reference(id=1329529120058355963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=王菲菲, 符合, 任进, 等. siRNA药物研究进展[J]. 中国新药杂志, 2022, 31(5): 427-434., articleTitle=null, refAbstract=null), Reference(id=1329529121643802877, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=McDougall R, Ramsden D, Agarwal S,
et al. The nonclinical disposition and pharmacokinetic/pharmacodynamic properties of
N-acetylgalactosamine-conjugated small interfering RNA are highly predictable and build confidence in translation to human[J]. Drug Metab Dispos, 2022, 50(6): 781-797., articleTitle=null, refAbstract=null), Reference(id=1329529121731883262, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Boianelli A, Aoki Y, Ivanov M,
et al. Cross-species translation of biophase half-life and potency of GalNAc-conjugated siRNAs[J]. Nucleic Acid Ther, 2022, 32(6): 507-512., articleTitle=null, refAbstract=null), Reference(id=1329529121836740863, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Janas MM, Harbison CE, Perry VK,
et al. The nonclinical safety profile of GalNAc-conjugated RNAi therapeutics in subacute studies[J]. Toxicol Pathol, 2018, 46(7): 735-745., articleTitle=null, refAbstract=null), Reference(id=1329529121916432640, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Sutherland JE, Hettinger JL, Chan A,
et al. Nonclinical safety profile of revusiran, a 1st-generation GalNAc-siRNA conjugate for treatment of hereditary transthyretin-mediated amyloidosis[J]. Nucleic Acid Ther, 2020, 30(1): 33-49., articleTitle=null, refAbstract=null), Reference(id=1329529121991930113, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Scott LJ. Givosiran: first approval[J]. Drugs, 2020, 80(3): 335-339., articleTitle=null, refAbstract=null), Reference(id=1329529122059038978, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Scott LJ, Keam SJ. Lumasiran: first approval[J]. Drugs, 2021, 81(2): 277-282., articleTitle=null, refAbstract=null), Reference(id=1329529122138730755, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Lamb YN. Inclisiran: first approval[J]. Drugs, 2021, 81(3): 389-395., articleTitle=null, refAbstract=null), Reference(id=1329529122247782660, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Keam SJ. Vutrisiran: first approval[J]. Drugs, 2022, 82(13): 1419-1425., articleTitle=null, refAbstract=null), Reference(id=1329529122327474437, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Yonezawa S, Koide H, Asai T. Recent advances in siRNA delivery mediated by lipid-based nanoparticles[J]. Adv Drug Deliv Rev, 2020, (154-155): 64-78., articleTitle=null, refAbstract=null), Reference(id=1329529122566549766, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Albertsen CH, Kulkarni JA, Witzigmann D,
et al. The role of lipid components in lipid nanoparticles for vaccines and gene therapy[J]. Adv Drug Deliv Rev, 2022, 188: 114416., articleTitle=null, refAbstract=null), Reference(id=1329529122725933319, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=赵雅楠, 何伟, 邵泉林, 等. 可电离脂质纳米粒用于siRNA递送的研究进展[J]. 药学学报, 2023, 58(8): 2292-2299., articleTitle=null, refAbstract=null), Reference(id=1329529122834985224, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Hirai Y, Saeki R, Song F,
et al. Charge-reversible lipid derivative: a novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery[J]. Int J Pharm, 2020, 585: 119479., articleTitle=null, refAbstract=null), Reference(id=1329529122927259913, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Hashimoto M, Yonezawa S, Furan S,
et al. Increasing the siRNA knockdown efficiency of lipid nanoparticles by morphological transformation with the use of dihydrosphingomyelin as a helper lipid[J]. Biomater Sci, 2023, 11(9): 3269-3277., articleTitle=null, refAbstract=null), Reference(id=1329529123090837770, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Kim IG, Jung WH, You G,
et al. Efficient delivery of globotriaosylceramide synthase siRNA using polyhistidine-incorporated lipid nanoparticles[J]. Macromol Biosci, 2023, 23(4): e2200423., articleTitle=null, refAbstract=null), Reference(id=1329529123153752331, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Food and Drug Administration. FDA drug approvals and databases[EB/OL]. [2023-06-03]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210922s000lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1329529123225055500, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Adams D, Gonzalez-Duarte A, O'riordan WD,
et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis[J]. N Engl J Med, 2018, 379(1): 11-21., articleTitle=null, refAbstract=null), Reference(id=1329529123317330189, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release[J]. Cell Mol Life Sci, 2018, 75(2): 193-208., articleTitle=null, refAbstract=null), Reference(id=1329529123459936526, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Kim H, Jang H, Cho H,
et al. Recent advances in exosome-based drug delivery for cancer therapy[J]. Cancers (Basel), 2021, 13(17): 4435., articleTitle=null, refAbstract=null), Reference(id=1329529123640291599, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Shan S, Chen J, Sun Y,
et al. Functionalized macrophage exosomes with panobinostat and PPM1D-siRNA for diffuse intrinsic pontine gliomas therapy[J]. Adv Sci (Weinh), 2022, 9(21): e2200353., articleTitle=null, refAbstract=null), Reference(id=1329529123766120720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhan Q, Yi KK, Cui XT,
et al. Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy[J]. Neuro Oncol, 2022, 24(11): 1871-1883., articleTitle=null, refAbstract=null), Reference(id=1329529123933892881, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=文武龙, 张炜烨, 张筠昊, 等. 外泌体载药系统的研究进展[J]. 中国药房, 2023, 34(10): 1271-1275., articleTitle=null, refAbstract=null), Reference(id=1329529124131025170, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Kaban K, Hinterleitner C, Zhou Y,
et al. Therapeutic silencing of Bcl-2 using NK cell-derived exosomes as a novel therapeutic approach in breast cancer[J]. Cancers (Basel), 2021, 13(10): 2397., articleTitle=null, refAbstract=null), Reference(id=1329529124210716947, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Lin D, Zhang H, Liu R,
et al. IRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation[J]. Mol Oncol, 2021, 15(12): 3430-3446., articleTitle=null, refAbstract=null), Reference(id=1329529124323963156, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Roy A, As SG, Ganesh PS,
et al. Exosome mediated cancer therapeutic approach: present status and future prospectives[J]. Asian Pac J Cancer Prev, 2023, 24(2): 363-373., articleTitle=null, refAbstract=null), Reference(id=1329529124420432149, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Warren MR, Zhang CZ, Vedadghavami A,
et al. Milk exosomes with enhanced mucus penetrability for oral delivery of siRNA[J]. Biomater Sci, 2021, 9(12): 4260-4277., articleTitle=null, refAbstract=null), Reference(id=1329529126081376534, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu QH, Dai GR, Wu Y,
et al. IRGD-modified exosomes-delivered Bcl6 siRNA inhibit the progression of diffuse large B-cell lymphoma[J]. Front Oncol, 2022, 12: 822805., articleTitle=null, refAbstract=null), Reference(id=1329529126203011351, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Zorko M, Langel Ü. Cell-penetrating peptides[J]. Methods Mol Biol, 2022, 2383: 3-32., articleTitle=null, refAbstract=null), Reference(id=1329529126282703128, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=Di L. Strategic approaches to optimizing peptide ADME properties[J]. AAPS J, 2015, 17(1): 134-143., articleTitle=null, refAbstract=null), Reference(id=1329529126408532249, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=Kim GC, Cheon DH, Lee Y. Challenge to overcome current limitations of cell-penetrating peptides[J]. Biochim Biophys Acta Proteins Proteom, 2021, 1869(4): 140604., articleTitle=null, refAbstract=null), Reference(id=1329529126563721498, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=Porosk L, Arukuusk P, Põhako K,
et al. Enhancement of siRNA transfection by the optimization of fatty acid length and histidine content in the CPP[J]. Biomater Sci, 2019, 7(10): 4363-4374., articleTitle=null, refAbstract=null), Reference(id=1329529126714716443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu Y, Wan HH, Tian DM,
et al. Development and characterization of high efficacy cell-penetrating peptide via modulation of the histidine and arginine ratio for gene therapy[J]. Materials (Basel), 2021, 14(16): 4674., articleTitle=null, refAbstract=null), Reference(id=1329529126794408220, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=Yang YY, Zhang W, Liu H,
et al. Cell-penetrating peptide-modified graphene oxide nanoparticles loaded with rictor sirna for the treatment of triple-negative breast cancer[J]. Drug Des Devel Ther, 2021, 15: 4961-4972., articleTitle=null, refAbstract=null), Reference(id=1329529126899265821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang C, Yuan W, Wu Y,
et al. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells[J]. Life Sci, 2021, 266: 118886., articleTitle=null, refAbstract=null), Reference(id=1329529127016706334, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=Bashir SM, Rather GA, Patrício A,
et al. Chitosan nanoparticles: a versatile platform for biomedical applications[J]. Materials (Basel), 2022, 15(19): 6521., articleTitle=null, refAbstract=null), Reference(id=1329529127104786719, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=Sonin D, Pochkaeva E, Zhuravskii S,
et al. Biological safety and biodistribution of chitosan nanoparticles[J]. Nanomaterials (Basel), 2020, 10(4): 810., articleTitle=null, refAbstract=null), Reference(id=1329529127251587360, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=Sun P, Huang W, Jin MJ,
et al. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis[J]. Int J Nanomedicine, 2016, 11: 4931-4945., articleTitle=null, refAbstract=null), Reference(id=1329529127335473441, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=Ashrafizadeh M, Delfi M, Hashemi F,
et al. Biomedical application of chitosan-based nanoscale delivery systems: potential usefulness in siRNA delivery for cancer therapy[J]. Carbohydr Polym, 2021, 260: 117809., articleTitle=null, refAbstract=null), Reference(id=1329529127423553826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang WH, Xu WH, Lan Y,
et al. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer[J]. Int J Nanomedicine, 2019, 14: 5287-5301., articleTitle=null, refAbstract=null), Reference(id=1329529127503245603, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=Luo JX, Chen JF, Liu Y,
et al. A novel form of arginine-chitosan as nanoparticles efficient for siRNA delivery into mouse leukemia cells[J]. Int J Mol Sci, 2023, 24(2): 1040., articleTitle=null, refAbstract=null), Reference(id=1329529127582937380, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=Khan S, Madni A, Shah H,
et al. Folate decorated lipid chitosan hybrid nanoparticles of 5-fluorouracil for enhanced anticancer efficacy against colon cancer[J]. Int J Biol Macromol, 2022, 222(Pt A): 497-508., articleTitle=null, refAbstract=null), Reference(id=1329529127641657637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=Shaabani E, Sharifiaghdam M, de Keersmaecker H,
et al. Layer by layer assembled chitosan-coated gold nanoparticles for enhanced siRNA delivery and silencing[J]. Int J Mol Sci, 2021, 22(2): 831., articleTitle=null, refAbstract=null), Reference(id=1329529127738126630, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhou X, Smith QR, Liu XL. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases[J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2021, 13(4): e1695., articleTitle=null, refAbstract=null), Reference(id=1329529127813624103, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=Sava V, Fihurka O, Khvorova A,
et al. Kinetics of HTT lowering in brain of YAC 128 mice following single and repetitive intranasal dosing of siRNA packaged in chitosan-based nanoparticle[J]. J Drug Deliv Sci Technol, 2021, 63: 102517., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329529111778799806, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, xref=1., ext=[AuthorCompanyExt(id=1329529111841714367, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529111778799806, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1329529111854297280, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529111778799806, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1329529112806404289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, xref=2., ext=[AuthorCompanyExt(id=1329529112848347330, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112806404289, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Shanghai Innostar Biotech CO., Ltd., Shanghai 201203, China), AuthorCompanyExt(id=1329529112860930243, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112806404289, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海益诺思生物技术股份有限公司,上海 201203)]), AuthorCompany(id=1329529112965787844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, xref=3., ext=[AuthorCompanyExt(id=1329529112990953669, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112965787844, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
3.Shenzhen Innostar Institute of Biomedical Safety Evaluation and Research Co., Ltd., Shenzhen 518000, Guangdong Province, China), AuthorCompanyExt(id=1329529113003536582, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529109954277563, companyId=1329529112965787844, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
3.深圳市益诺思生物医药安全评价研究院有限公司,广东 深圳 518000)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.07.015, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.07.015, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.07.015, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.07.015, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1720540800000, fullTextJson=null, articleText=null, reference=null)